Pulmonary vein region ablation in experimental vagal atrial fibrillation: role of pulmonary veins versus autonomic ganglia.
BACKGROUND
Pulmonary vein (PV) -encircling radiofrequency ablation frequently is effective in vagal atrial fibrillation (AF), and there is evidence that PVs may be particularly prone to cholinergically induced arrhythmia mechanisms. However, PV ablation procedures also can affect intracardiac autonomic ganglia. The present study examined the relative role of PVs versus peri-PV autonomic ganglia in an experimental vagal AF model.


RESULTS
Cholinergic AF was studied under carbachol infusion in coronary perfused canine left atrial PV preparations in vitro and with cervical vagal stimulation in vivo. Carbachol caused dose-dependent AF promotion in vitro, which was not affected by excision of all PVs. Sustained AF could be induced easily in all dogs during vagal nerve stimulation in vivo both before and after isolation of all PVs with encircling lesions created by a bipolar radiofrequency ablation clamp device. PV elimination had no effect on atrial effective refractory period or its responses to cholinergic stimulation. Autonomic ganglia were identified by bradycardic and/or tachycardic responses to high-frequency subthreshold local stimulation. Ablation of the autonomic ganglia overlying all PV ostia suppressed the effective refractory period-abbreviating and AF-promoting effects of cervical vagal stimulation, whereas ablation of only left- or right-sided PV ostial ganglia failed to suppress AF. Dominant-frequency analysis suggested that the success of ablation in suppressing vagal AF depended on the elimination of high-frequency driver regions.


CONCLUSIONS
Intact PVs are not needed for maintenance of experimental cholinergic AF. Ablation of the autonomic ganglia at the base of the PVs suppresses vagal responses and may contribute to the effectiveness of PV-directed ablation procedures in vagal AF.
Lemola
Kristina
K
Department of Medicine, Montreal Heart Institute, Montreal, Quebec, Canada.
Chartier
Denis
D
Yeh
Yung-Hsin
YH
Dubuc
Marc
M
Cartier
Raymond
R
Armour
Andrew
A
Ting
Michael
M
Sakabe
Masao
M
Shiroshita-Takeshita
Akiko
A
Comtois
Philippe
P
Nattel
Stanley
S
D000818:Animals; D001281:Atrial Fibrillation / Q000628:therapy*; D002217:Carbachol; D017115:Catheter Ablation / Q000379:methods*; D018679:Cholinergic Agonists; D004195:Disease Models, Animal; D004285:Dogs; D005725:Ganglia, Autonomic / Q000601:surgery*; D011667:Pulmonary Veins / Q000503:physiopathology*; D014630:Vagus Nerve / Q000503:physiopathology*
D018679:Cholinergic Agonists; D002217:Carbachol